Naoto Takahashi

Akita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 414 publications

Ocular Follicular Lymphoma with Marginal Zone Differentiation: A Diagnostic Pitfall Mimicking MALT Lymphoma.

Ocular Follicular Lymphoma with Marginal Zone Differentiation: A Diagnostic Pitfall Mimicking MALT Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: July 20, 2026

Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.

Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report.

Journal: Internal medicine (Tokyo, Japan)

Published: June 10, 2026

Blood sLOX-1 Is Beneficial for Determining Severity of Neonatal Hypoxic-Ischemic Encephalopathy: A Nationwide Prospective Cohort Study.

Blood sLOX-1 Is Beneficial for Determining Severity of Neonatal Hypoxic-Ischemic Encephalopathy: A Nationwide Prospective Cohort Study.

Journal: Medical sciences (Basel, Switzerland)

Published: May 18, 2026

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

Journal: Blood advances

Published: May 12, 2026

Video-Assisted Thoracoscopic Surgery for Empyema Secondary to Upper Gastrointestinal Leakage After Surgical or Endoscopic Intervention: A Multicenter Comparative Study.

Video-Assisted Thoracoscopic Surgery for Empyema Secondary to Upper Gastrointestinal Leakage After Surgical or Endoscopic Intervention: A Multicenter Comparative Study.

Journal: Asian journal of endoscopic surgery

Published: May 06, 2026

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

Journal: Blood advances

Published: May 05, 2026

Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysis.

Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysis.

Journal: Cancer chemotherapy and pharmacology

Published: May 04, 2026

Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia.

Therapeutic drug monitoring guides personalized ponatinib dose reduction for chronic myeloid leukemia.

Journal: International journal of hematology

Published: April 12, 2026

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

Journal: International journal of hematology

Published: April 10, 2026

Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study.

Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study.

Journal: Cancer medicine

Published: March 20, 2026

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Journal: British journal of haematology

Published: March 12, 2026

The challenge of achieving treatment-free remission for chronic myeloid leukemia

The challenge of achieving treatment-free remission for chronic myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 04, 2026

Showing 1-12 of 414

Last Updated: 09/26/2026